⌘K
Loading ticker…
As of 2026-08-21, CorMedix Inc. (CRMD) has a 3-month relative strength percentile of 51 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.2%, relative volume 1.05×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
CRMD appears in 1 ETF as of Jun 2026: PSC at 0.06% weight, $1M notional.
Held by 47 ETFs · $70M across latest filings · largest weight 1.33% (RNIN).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PSC | 0.06% | $1M | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CRMD Jan avg: -6.30% median: -9.35% win: 50% σ: 26.70% n: 4 2022-04-12 → 2026-07-31 | CRMD Feb avg: 1.52% median: -2.90% win: 50% σ: 12.94% n: 4 2022-04-12 → 2026-07-31 | CRMD Mar avg: -5.83% median: -1.27% win: 50% σ: 25.34% n: 4 2022-04-12 → 2026-07-31 | CRMD Apr avg: 14.58% median: 19.32% win: 80% σ: 29.26% n: 5 2022-04-12 → 2026-07-31 | CRMD May avg: 7.03% median: 0.29% win: 60% σ: 15.41% n: 5 2022-04-12 → 2026-07-31 | CRMD Jun avg: -3.37% median: -6.99% win: 40% σ: 17.33% n: 5 2022-04-12 → 2026-07-31 | CRMD Jul avg: 8.20% median: 5.77% win: 60% σ: 15.56% n: 5 2022-04-12 → 2026-07-31 | CRMD Aug avg: 5.35% median: 9.58% win: 50% σ: 32.42% n: 4 2022-04-12 → 2026-07-31 (current) | CRMD Sep avg: -5.25% median: -14.46% win: 25% σ: 23.81% n: 4 2022-04-12 → 2026-07-31 | CRMD Oct avg: 5.67% median: 2.09% win: 50% σ: 14.08% n: 4 2022-04-12 → 2026-07-31 | CRMD Nov avg: 3.77% median: -4.27% win: 25% σ: 21.54% n: 4 2022-04-12 → 2026-07-31 | CRMD Dec avg: 4.46% median: 8.57% win: 75% σ: 16.65% n: 4 2022-04-12 → 2026-07-31 |